Vaccine provides protection against five diseases

Infanrix-IPV+Hib is a multi-component vaccine that provides protection against diphtheria, tetanus, pertussis, polio and invasive diseases caused by Haemophilus influenzae type b.

Infanrix-IPV+Hib is appropriate for the active immunisation of children from age two months.

Primary immunisation is a course of two or three doses, separated by a minimum of four weeks between each dose. A booster dose should be given at least six months after the last priming dose, preferably between 11 and 13 months of age. The vaccine is not suitable for children over 36 months of age.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB1 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New shingles vaccine awaits decision on NHS use

New shingles vaccine awaits decision on NHS use

Shingrix, which is now available privately in the UK,...

Products coming soon - live tracker

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New products - live tracker

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...